Dallas Drugs Private Limited - Company Profile

It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2012.
2012 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Dallas Drugs Private Limited

Dallas Drugs Private Limited, a active private limited company, was established on 25 April 2012 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U15400CH2012PTC033748. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.00 Cr.

Formerly known as Friska Foods Private Limited. It upholds a compliant status. Employing 23 professional, Its leadership includes Rajesh Gupta (Director), Anil Kumar (Director). Past directors included Amrinder Singh Sidhu, Pukhraj Sidhu. It holds ₹11.28 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sco No. 805, 1St Floor (Half Portion At 1St Floor) N.A.C Manimajra,, Chandigarh, Chandigarh, 160002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15400CH2012PTC033748

  • Registration Number

    033748

  • Incorporation Date

    25 April 2012

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 13 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 11.28 Cr
  • Revenue Growth **** -18.72%
  • Profit Growth **** 105.72%
  • Ebitda **** 626.51%
  • Net Worth 17.34%
  • Total Assets -11.10%
Company report

Dallas Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dallas Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dallas Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Gupta Director 29 Sep 2018 Current
Anil Kumar Director 29 Sep 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Oct 2018 Past
Pramod Abcsdd Director 02 Oct 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dallas Drugs.

Dallas Drugs Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 18.72% decrease. The company also saw a substantial improvement in profitability, with a 105.72% increase in profit. The company's net worth Soared by an impressive increase of 17.34%.

Dallas Drugs revenue growth over time
Dallas Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -18.72%
*******
*******
*******
*******
Revenue from Operations
*******
 -18.68%
*******
*******
*******
*******
Total Assets
*******
 -11.10%
*******
*******
*******
*******
Profit or Loss
*******
 105.72%
*******
*******
*******
*******
Net Worth
*******
 17.34%
*******
*******
*******
*******
EBITDA
*******
 626.51%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dallas Drugs?

Unlock access to Dallas Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹112,800,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 11.28 Cr
Latest Charge Details
Date Lender Amount Status
20 Apr 2019 State Bank Of India ₹11.28 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Dallas Drugs?

Dallas Drugs has a workforce of 23 employees as of Dec 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dallas Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dallas Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dallas Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Dallas Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Dallas Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India of Rs. 11.28 Cr registered on 20 Apr 2019 with Charge ID 100268414 was modified on 10 May 2023. was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 11.28 Cr with Charge ID 100268414 was registered on 20 Apr 2019. was completed.

  • Director Appointment

    Progress on Rajesh Gupta was appointed as a Director was appointed as a Director on 29 Sep 2018 & has been associated with this company since 7 years 6 months . was documented.

  • Director Appointment

    Progress on Anil Kumar was appointed as a Director was appointed as a Director on 29 Sep 2018 & has been associated with this company since 7 years 6 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dallas Drugs Private Limited?

The CIN of Dallas Drugs Private Limited is U15400CH2012PTC033748.

Where is Dallas Drugs Private Limited headquartered?

Dallas Drugs Private Limited is headquartered at Sco No. 805, 1St Floor (Half Portion At 1St Floor) N.A.C Manimajra,, Chandigarh, Chandigarh, 160002.

When was Dallas Drugs Private Limited incorporated?

Dallas Drugs Private Limited was incorporated on 25 April 2012.

Who are the current directors of Dallas Drugs Private Limited?

The current directors of Dallas Drugs Private Limited are

What is the primary industry of Dallas Drugs Private Limited?

The primary industry of Dallas Drugs Private Limited is Manufacturing.

Is Dallas Drugs Private Limited a listed company?

Dallas Drugs Private Limited is unlisted.

What is the capital structure of Dallas Drugs Private Limited?

The authorized capital of Dallas Drugs Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.00 Cr.

What is the compliance status of Dallas Drugs Private Limited?

The compliance status of Dallas Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available